Toxicity of chemotherapy

Hematology/Oncology Clinics of North America

Volumn 10, Issue 4, 1996, Pages 967-990

  Lowenthal, R M ^a   Eaton, K ^a  

^a ROYAL HOBART HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BLEEDING; BONE MARROW DEPRESSION; CANCER CHEMOTHERAPY; CARCINOGENICITY; CARDIOTOXICITY; DIGESTIVE SYSTEM FUNCTION DISORDER; HYPERSENSITIVITY REACTION; INFERTILITY; LIVER TOXICITY; PARANEOPLASTIC SYNDROME; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; SKIN PIGMENTATION; THROMBOSIS;

EID: 0030001152     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70378-6     Document Type: Article

References (156)

1. J. Alexander N. Dainiak H.J. Berger Serial assessment of doxorubicin cardiotoxic-ity with quantitative radionuclide angiocardiography N Engl J Med 300 1979 278
2. B.S. Andersson B.M. Cogan M.J. Keating Subacute pulmonary failure complicating therapy with high dose Ara-C in acute leukemia Cancer 56 1985 2181
3. S.A. Aristizabal Complications from combination chemotherapy and irradiation in oat cell lung cancer [letter] JAMA 237 1977 1824
4. B. Bannwarth L. Labat Y. Moride Methotrexate in rheumatoid arthritis. An update Drugs 47 1994 25
5. C. Barton J. Waxman Effects of chemotherapy on fertility Blood Rev 4 1990 187
6. R.L. Bick Alterations of hemostasis in malignancy R.L. Bick Hematology. Clinical and Laboratory Practice ed 1 1993 Mosby St Louis 1583
7. Bishop JF, Matthews JP, Young GA, et al: A randomized study of high dose cytarabine in induction in acute myeloid leukemia. Blood, in press
8. G. Biti E. Cellai S.M. Magrini Second solid tumors and leukemia after treatment for Hodgkin's disease: Analysis of 1121 patients from a single institution Int J Radiat Oncol Biol Phys 29 1994 25
9. S.M. Blaney F.M. Balis D.G. Poplack Current pharmacological treatment approaches to central nervous system leukaemia Drugs 41 1991 702
10. M.L. Blankenship Drugs and alopecia Australas J Dermatol 24 1983 100
11. J. Blatt J.J. Mulvihill J.L. Ziegler Pregnancy outcome following cancer chemotherapy Am J Med 69 1980 828
12. W.A. Bleyer J.C. Drake B.A. Chabner Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia N Engl J Med 289 1973 770
13. R.H. Blum S.K. Carter K. Agre A clinical review of bleomycin--a new antineoplastic agent Cancer 31 1973 903
14. H.L. Borison S.C. Wang Physiology and pharmacology of vomiting Pharmacol Rev 5 1953 193
15. J.F. Buchanan L.J. Davis Drug-induced infertility Drug Intelligence and Clinical Pharmacy 18 1984 122
16. L.J. Burns Ocular toxicities of chemotherapy Semin Oncol 19 1992 492
17. A.U. Buzdar S.S. Legha M.A. Luna Pulmonary toxicity of mitomycin Cancer 45 1980 236
18. M. Cain P. Tenni Drug monographs Drug Therapy in Cancer. A Practical Guide for Health Professionals 1992 Society of Hospital Pharmacists of Australia Sydney
19. A. Calvert A. Horwich E. Newlands Carboplatin or cisplatin? Lancet 2 1988 577
20. G.P. Canellos J.R. Anderson K.J. Propert Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD N Engl J Med 327 1992 1478
21. C.W. Carson G.W. Cannon M.J. Egger Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate Semin Arthritis Rheum 16 1987 186
22. R.M. Chapman Effect of cytotoxic therapy on sexuality and gonadal function Semin Oncol 9 1982 84
23. R.M. Chapman S.B. Sutcliffe J.S. Malpas Cytotoxic-induced ovarian failure in women with Hodgkin's disease. 1. Hormone function JAMA 242 1979 1877
24. R.M. Chapman S.B. Sutcliffe J.S. Malpas Male gonadal dysfunction in Hodgkin's disease. A prospective study JAMA 245 1981 1323
25. R.M. Chapman S.B. Sutcliffe L.H. Rees Cyclical combination chemotherapy and gonadal dysfunction. Retrospective study in males Lancet 1 1979 285
26. L.F. Cohen J.E. Balow I.T. Magrath Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma Am J Med 68 1980 486
27. J.A. Cooper D.A. Woo R.A. Matthay Drug induced pulmonary disease: Part 1: Cytotoxic drugs Am Rev Respir Dis 133 1986 321
28. J. Crawford H. Ozer R. Stoller Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small cell lung cancer N Engl J Med 325 1991 164
29. R.G. Crounse E.J. Van Scott Changes in scalp hair roots as a measure of toxicity from cancer chemotherapeutic drugs J Invest Dermatol 35 1960 83
30. L.X. Cubeddu Mechanisms by which cancer chemotherapeutic drugs induce emesis Sernin Oncol 19 1992 2
31. C.F. Curran J.K. Luce Ocular adverse reactions associated with Adriamycin (doxorubi-cin) Am J Ophthalmol 108 1989 709
32. G.J. D'Angio S. Farber C.L. Maddock Potentiation of x-ray effects by actinomycin D Radiology 73 1959 175
33. G. Daugaard U. Abildgaard N.H. Holstein-Rathlou Renal tubular function in patients treated with high-dose cisplatin Clin Pharmacol Ther 44 1988 164
34. R.A. DeFronzo O.M. Colvin H. Braine Cyclophosphamide and the kidney Cancer 33 1974 483
35. J.D. DeSpain Dermatologic toxicity of chemotherapy Semin Oncol 19 1992 501
36. D.C. Doll R.B. Weiss B.F. Issell Mitomycin: Ten years after approval for marketing J Clin Oncol 3 1985 276
37. J.H. Doroshow G.Y. Locker D.E. Gaasterland Ocular irritation from high-dose methotrexate therapy: Pharmacokinetics of drug in the tear film Cancer 48 1981 2158
38. R.T. Dorr D.D. Von Hoff Cancer Chemotherapy Handbook ed 2 1994 Appleton and Lange Norwalk, CT
39. W.G. Dunagin Clinical toxicity of chemotherapeutic agents: Dermatologic toxicity Semin Oncol 9 1982 14
40. J.R. Durant M.J. Norgard T.M. Murad Pulmonary toxicity associated with bischlor-ethylnitrosourea (BCNU) Ann Intern Med 90 1979 191
41. E. Etcubanas J.R. Wilbur Uncommon side effects of Adriamycin (NSC-123127) Cancer Chemother Rep 58 1974 757
42. M.E. Eyster Melphalan (Alkeran) erythrocyte agglutinin and hemolytic anemia Ann Intern Med 66 1967 573
43. K.F. Fairley J.V. Barrie W. Johnson Sterility and testicular atrophy related to cyclophos-phamide therapy Lancet 1 1972 568
44. D.S. Fischer M.T. Knobf Dermatologic toxicity The Cancer Chemotherapy Handbook ed 3 1989 Year Book Medical Publishers Chicago
45. P.I. Folb Cytostatic and immunosuppressive drugs M.N.G. Dukes Meyler's Side Effects of Drugs ed 12 1992 Elsevier New York 1107
46. L. Gauci B. Serrou Changes in hair pigmentation associated with cancer chemotherapy [letter] Cancer Treat Rep 64 1980 193
47. E.P. Getaz S. Beckley J. Fitzpatrick Cisplatin-induced hemolysis N Engl J Med 302 1980 334
48. S.J. Ginsberg R.L. Comis The pulmonary toxicity of antineoplastic agents Semin Oncol 9 1982 34
49. M.A. Goldberg J.H. Antin E.C. Guinan Cyclophosphamide cardiotoxicity: An analysis of dosing as a risk factor Blood 68 1986 1114
50. P.L. Goldiner G.C. Carlon E. Cvitkovic Factors influencing postoperative morbidity and mortality in patients treated with bleomycin Br Med J 1 1978 t664
51. J.C. Gonzalez-Vitale D.M. Hayes E. Cvitkovic Acute renal failure after cis-dichlorodiammineplatinum(II) and gentamicin-cephalothin therapies Cancer Treat Rep 62 1978 693
52. L.S. Goodman M.M. Wintrobe W. Dameshek Nitrogen mustard therapy: Use of methylbis (B-chloroethyl) amino hydrochloride for Hodgkin's disease, lymphosar-coma, leukemia and certain allied and miscellaneous disorders JAMA 132 1946 126
53. A.M. Goorin A.R. Chauvenet A.R. Perez-Atayde Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancer J Pediatr 116 1990 144
54. R.J. Gralla Antiemetic therapy V.T. Devita S. Hellman S.A. Rosenberg Cancer: Principles and Practice of Oncology ed 4 1993 JB Lippincott Philadelphia 2338
55. L. Green A. Schattner H. Berkenstadt Severe reversible interstitial pneumonitis induced by low dose methotrexate: Report of a case and review of the literature J Rheumatol 15 1988 110
56. D. Greenbaum H.F. Hope-Stone Dangers of uric acid excretion during treatment of leukaemia and lymphoma Lancet 1 1959 73
57. M.H. Greene E.L. Harris D.M. Gershenson Melphalan may be a more potent leukemogen than cyclophosphamide Ann Intern Med 105 1986 360
58. J.D. Griffin M.B. Garnick Eye toxicity of cancer chemotherapy: A review of the literature Cancer 48 1981 1539
59. S.M. Grunberg P.J. Hesketh Control of chemotherapy-induced emesis N Engl J Med 329 1990 1790
60. S.R. Gunstream J.J. Seidenfeld R.E. Sobonya Mitomycin-associated lung disease Cancer Treat Rep 67 1983 301
61. B.E. Heard R.A. Cooke Busulphan lung Thorax 23 1968 187
62. A.F. Hood Cutaneous side effects of cancer chemotherapy Med Clin North Am 70 1986 187
63. J. Horton K.B. Olson J. Sullivan 5-fluorouracil in cancer: An improved regimen Ann Intern Med 73 1970 897
64. C.F. Hoyle M. de Bastos K. Wheatley AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: Results from the MRC's 9th AML trial Br J Haematol 72 1989 45
65. R.J. Ignoffo M.A. Friedman Therapy of local toxicities caused by extravasation of cancer chemotherapeutic agents Cancer Treat Rev 7 1980 17
66. A.P. Jones S.M. Crawford Anthracycline-induced toxicity affecting palmar and plantar skin Br J Cancer 59 1989 814
67. J.M. Kaldor N.E. Day E.A. Clarke Leukemia following Hodgkin's disease N Engl J Med 322 1990 7
68. J.M. Kaldor N.E. Day F. Pettersson Leukemia following chemotherapy for ovarian cancer N Engl J Med 322 1990 1
69. K. Kaushansky Thrombopoietin: The primary regulator of platelet production Blood 86 1995 419
70. A.C. Kay A. Saven C.J. Carrera 2-chlorodeoxyadenosine treatment of low-grade lymphomas J Clin Oncol 10 1992 371
71. T. Khansur A. Kennedy Case reports. Cisplatin-induced hemolytic uremic syndrome Am J Med Sci 301 1991 390
72. N.S. Kleiman D.E. Lehane C.E. Geyer Prinzmetal's angina during 5-fiuorouracil chemotherapy Am J Med 82 1987 566
73. H. Kreisman N. Wolkove Pulmonary toxicity of antineoplastic therapy Semin Oncol 19 1992 508
74. E.D. Kreuser W.D. Hetzel D.O. Billia Gonadal toxicity following cancer therapy in adults: Significance, diagnosis, prevention and treatment Cancer Treat Rev 17 1990 169
75. M.G. Kris R.J. Gralla R.A. Clark Incidence, course, and severity of delayed nausea and vomiting following the administration of high dose cisplatin J Clin Oncol 3 1985 1379
76. V.J. Land W.W. Sutow D.J. Fernbach Toxicity of L-asparaginase in children with advanced leukemia Cancer 30 1972 339
77. J. Lees Chemotherapy-induced nausea and vomiting and the clinical use of antiemet-ics M. CaM P. Tenni Drug Therapy in Cancer. A Practical Guide for Health Professionals 1992 Society of Hospital Pharmacists of Australia Sydney
78. G. Lehne K. Lote Pulmonary toxicity of cytotoxic and immunosuppressive agents: A review Acta Oncol 29 1990 113
79. R.D. Lentz J. BergsteM M.W. Steffes Postpubertal evaluation of gonadal function following cyclophosphamide therapy before and during puberty J Pediatr 91 1977 385
80. M. Levitt J.C. Marsh R.C. DeConti Combination sequential chemotherapy in advanced reticulum cell sarcoma Cancer 29 1972 630
81. S.E. Lipshultz S.D. Colan R.D. Gelber Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia M childhood N Engl J Med 324 1991 808
82. W. Lorenz H.J. Reimann A. Schmal Histamine release in dogs by Cremophor E1 and its derivatives: Oxethylated oleic acid is the most effective constituent Agents Actions 7 1977 63
83. R.M. Lowenthal D.R. Challis A.E. Griffiths Transfusion-associated graft-versus-host disease: Report of an occurrence following the administration of irradiated blood Transfusion 33 1993 524
84. N.E. Madias J.T. Harrington Platinum nephrotoxicity Am J Med 65 1978 307
85. A.G. Maiche K. Lappalainen L. Teerenhovi Renal insufficiency in patients treated with high dose methotrexate Acta Oncol 27 1988 73
86. G.B. McDonald M.S. Hinds L.D. Fisher Veno-occlusive disease of the liver and multiorgan failure after BM transplantation: A cohort study of 355 patients Ann Intern Med 118 1993 255
87. W.P. McGuire E.K. Rowinsky N.B. Rosenshein Taxol: A unique anti-neoplastic agent with significant activity in advanced ovarian epithelial neoplasms Ann Intern Med 111 1989 273
88. S. Mcintosh D.L. Davidson R.T. O'Brien Methotrexate hepatotoxicity in children with leukemia J Pediatr 90 1977 1019
89. J. Middleton D. Franks R.B. Buchanan Failure of scalp hypothermia to prevent hair loss when cyclophosphamide is added to doxorubicin and vincristine Cancer Treat Rep 69 1985 373
90. D.G. Miller Alkylating agents and human spermatogenesis JAMA 217 1971 1662
91. E.P. Mitchell P.S. Schein Gastrointestinal toxicity of chemotherapeutic agents Semin Oncol 9 1982 52
92. E.P. Mitchell Gastrointestinal toxicity of chemotherapeutic agents Semin Oncol 19 1992 566
93. J.A. Moormeier S.F. Williams L.S. Kaminer High dose tri-alkylator chemotherapy with autologous stem cell rescue in patients with refractory malignancies J Natl Cancer Inst 82 1990 29
94. G.R. Morrow Management of chemotherapy-induced nausea and vomiting S. Rosenthal J.R. Carignan B.D. Smith Medical Care of the Cancer Patient ed 2 1993 WB Saunders Philadelphia 265
95. G.R. Morrow C. Morrell Behavioral treatment for anticipatory nausea and vomiting induced by cancer chemotherapy N Engl J Med 307 1982 1476
96. F.M. Muggia A.C. Louie B.I. Sikic Pulmonary toxicity of antitumor agents Cancer Treat Rev 10 1983 221
97. S.E. Myers R.L. Schilsky Prospects for fertility after cancer chemotherapy Semin Oncol 19 1992 597
98. R.A. Newbury-Ecob V.W. Noble P.R. Barbor Ifosfamide-induced Fanconi syndrome [letter] Lancet 1 1989 1328
99. D.W. Nixon Alterations in nail pigment with cancer chemotherapy Arch Intern Med 136 1976 1117
100. E. Oksenhendler P. Landais C. Cordonnier Acral erythema and systemic toxicity related to CHA induction therapy in acute myeloid leukemia Eur J Cancer Clin Oncol 25 1989 1181
101. A.R. Patel P.C. Shah H.L. Rhee Cyclophosphamide therapy and interstitial pulmonary fibrosis Cancer 38 1976 1542
102. W.P. Patterson G.P. Reams Renal toxicities of chemotherapy Semin Oncol 19 1992 521
103. M.D. Pavy E.L. Wiley M.D. Abeloff Hemolytic-uremic syndrome associated with mito-mycin therapy Cancer Treat Rep 66 1982 457
104. J. Pedersen-Bjergaard L. Specht S.O. Larsen Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkyl-ating agents, and time from chemotherapy Lancet 2 1987 83
105. N.F. Perks A.M. Lower F.M. Kelsey Cancer chemotherapy and fertility [letter] Br Med J 305 1992 51
106. D.E. Peterson Oral toxicity of chemotherapeutic agents Semin Oncol 19 1992 478
107. G.L. Phillips J.W. Fay G.P. Herzig Intensive 1,3-bis(2-chloroethyl)-l-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer Cancer 52 1983 1792
108. C.H. Pui R.C. Ribeiro M.L. Hancock Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia N Engl J Med 325 1991 1682
109. P. Richter J.C. Calamera M.C. Morgenfeld Effect of chlorambucil on spermatogen-esis in the human with malignant lymphoma Cancer 25 1970 1026
110. R.E. Rieselbach C.J. Bentzel E. Cotlove Uric acid excretion and renal function in the acute hyperuricemia of leukemia Am J Med 37 1964 872
111. J.W. Ringlein Management of nausea and vomiting and other acute side effects of cancer chemotherapy R.T. Skeel Handbook of Cancer Chemotherapy ed 3 1991 Little, Brown London 503
112. P.S. Pitch R.M. Hansen D.K. Heuer Ocular toxicity from high dose cytosine arabinoside Cancer 51 1983 430
113. B.A. Robinson B.M. Coils B.M. Fitzharris C.H. Atkinson Second malignant neoplasms in patients with Hodgkin's disease Aust NZ J Med 24 1994 368
114. H.P. Roeser A.E. Stocks A.J. Smith Testicular damage due to cytotoxic drugs and recovery after cessation of therapy Aust NZ J Med 8 1978 250
115. E.C. Rosenow J.L. Myers S.J. Swensen Drug-induced pulmonary disease. An update Chest 102 1992 239
116. S. Rosenthal S. Kaufman Vincristine neurotoxicity Ann Intern Med 80 1974 733
117. E.K. Rowinsky R.C. Donehower Paclitaxel (Taxol) N Engl J Med 332 1995 1004
118. P. Sandvei R. Nordhagen T.E. Michaelson Fluorouracil (5-FU) induced acute immune haemolytic anaemia Br J Haematol 65 1987 357
119. P.S. Schein S.H. Winokur Immunosuppressive and cytotoxic chemotherapy: Long-term complications Ann Intern Med 82 1975 84
120. R.L. Schilsky Renal and metabolic toxicities of cancer chemotherapy Semin Oncol 9 1982 75
121. R.L. Schilsky B.J. Lewis R.J. Sherins Gonadal dysfunction in patients receiving chemotherapy for cancer Ann Intern Med 93 1980 109
122. R.L. Schilsky R.J. Sherins S.M. Hubbard Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease Am J Med 71 1981 552
123. G. Scwartsmann A.W. Dekker J. Verhoef Complications of cytotoxic therapy M. Peckham M. Pinedo U. Veronesi Oxford Textbook of Oncology vol 2 1995 Oxford University Press New York
124. G. Searles R.J.R. McKendry Methotrexate pneumonitis in rheumatoid arthritis: Potential risk factors. Four case reports and a review of the literature J Rheumatol 14 1987 1164
125. M.E. Sears Erythema in areas of previous irradiation in patients treated with hydroxy-urea (NSC-32065) Cancer Chemother Rep 40 1964 31
126. C.A. Seipp Hair loss V.T. Devita S. Hellman S.A. Rosenberg Cancer: Principles and Practice of Oncology ed 4 1993 JB Lippincott Philadelphia 2394
127. R.G. Selker S.A. Jacobs P.B. Moore 1,3-Bis(2-chloroethyl)-l-nitrosourea (BCNU)-induced pulmonary fibrosis Neurosurgery 7 1980 560
128. L. Shall G.S. Lucas J.A. Whittaker P.J.A. Holt Painful red hands: A side effect of leukaemia therapy Br J Dermatol 119 1988 249
129. W.P. Sheridan G. Morstyn M. Wolf Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous BM transplantation Lancet 2 1989 891
130. R.J. Sherins Gonadal dysfunction V.T. Devita S. Hellman S.A. Rosenberg Cancer: Principles and Practice of Oncology ed 4 1993 JB Lippincott Philadelphia 2395
131. M.A. Siimes J. Rautonen Small testicles with impaired production of sperm in adult male survivors of childhood malignancies Cancer 65 1990 1303
132. J.L. Speyer M.D. Green A. Zeleniuch-Jacquotte ICRF-187 permits longer treatment with doxorubicin in women with breast cancer J Clin Oncol 10 1992 117
133. S. Spitz The histological effects of nitrogen mustards on human tumors and tissues Cancer 1 1948 383
134. J.S. Steinberg A.G. Wasserman Radionuclide ventriculography for evaluation and prevention of doxorubicin cardiotoxicity Clin Ther 7 1985 660
135. J.S. Steinberg A.J. Cohen A.G. Wasserman Acute arrhythmogenicity of doxorubi-cin administration Cancer 60 1987 1213
136. A.J. Swerdlow A.J. Douglas G.V. Hudson Risk of second primary cancers after Hodgkin's disease by type of treatment: Analysis of 2846 patients in the British National Lymphoma Investigation Br Med J 304 1992 1137
137. R. Taetle P.S. Dickman P.S. Feldman Pulmonary histopathologic changes associated with melphalan therapy Cancer 42 1978 1239
138. T. Takvorian L.M. Parker F.H. Hochberg Autologous BM transplantation: Host effects of high dose BCNU J Clin Oncol 1 1983 610
139. M. Tonato F. Roila Supportive care, anti-emetics and alimentation M. Peckham M. Pinedo U. Veronesi Oxford Textbook of Oncology vol 2 1995 Oxford University Press New York 2358
140. P.V. Tortorice M.B. O'Connell Management of chemotherapy-induced nausea and vomiting Pharmacotherapy 10 1990 129
141. L.B. Travis R.E. Curtis M. Stovall Risk of leukemia following treatment for non-Hodgkin's lymphoma J Natl Cancer Inst 86 1994 1450
142. F.E. van Leeuwen A.M. Chorus A.W. van den Belt-Dusebout Leukemia risk following Hodgkin's disease: Relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and BM damage J Clin Oncol 12 1994 1063
143. J. Verschoore J.L. Lagrange J.L. Boublil Pulmonary toxicity of a combination of low-dose doxorubicin and irradiation for inoperable lung cancer Radiother Oncol 9 1987 281
144. J. Verwey J. De Vries H.M. Pinedo Mitomycin C-induced renal toxicity, a dose dependent side effect? Eur J Cancer Clin Oncol 23 1987 195
145. D.D. Von Hoff M.W. Layard P. Basa Risk factors for doxorubicin-induced congestive heart failure Ann Intern Med 91 1979 710
146. D.D. Von Hoff R. Schilsky C.M. Reichert Toxic effects of cis-dichlorodiammi-neplatinum (II) in man Cancer Treat Rep 63 1979 1527
147. W.H. Wallace S.M. Shalet E.C. Crowne Gonadal dysfunction due to cis-platinum Med Pediatr Oncol 17 1989 409
148. G.L. Wame K.F. Fairley J.B. Hobbs Cyclophosphamide-induced ovarian failure N Engl J Med 289 1973 1159
149. J. Waxman Cancer, chemotherapy and fertility [editorial] Br Med J 290 1985 1096
150. J. Weick J. Kopecky F.R. Appelbaum A randomized investigation of high dose versus standard dose cytosine arabinoside with daunorubicin in patients with acute myelogenous leukemia [abstract] Proc Am Soc Clin Oncol 11 1992 261
151. H.D. Weiss M.D. Walker P.H. Wiernik Neurotoxicity of commonly used antineoplastic agents N Engl J Med 291 1974 127
152. R.B. Weiss A.J. Grillo-Lopez S. Marsoni Amsacrine-associated cardiotoxicity: An analysis of 82 cases J Clin Oncol 4 1986 918
153. R.B. Weiss N.J. Vogelzang Miscellaneous toxicities V.T. Devita S. Hellman S.A. Rosenberg Cancer: Principles and Practice of Oncology ed 4 1993 JB Lippin-cott Philadelphia 234
154. D.A. White D.E. Stover Severe bleomycin-induced pneumonitis. Clinical features and response to corticosteroids Chest 86 1984 723
155. T.J. Woodlock Oncologic emergencies S. Rosenthal J.R. Carignan B.D. Smith Medical Care of the Cancer Patient ed 2 1993 WB Saunders Philadelphia
156. D.W. Young Adverse drug reactions. Cytotoxic-induced nail pigmentation Current Therapeutics 35 1994 31